Gary Curhan

Research

Major research interests:

• Nephrolithiasis: Risk Factors and Prevention
• Analgesic Nephropathy
• Mild Chronic Kidney Disease
• Hypertension: Risk Factors and Prevention
• Gout: Epidemiology
• Hearing Loss: Epidemiology
• Tinnitus: Epidemiology

Dr. Curhan is a member of the Channing Laboratory and the Renal division at the Brigham and Women’s Hospital. Major active research interests include the epidemiology of nephrolithiasis, risk factors for renal function decline, epidemiology of hearing loss, novel risk factors for cardiovascular disease, health effects of analgesic use, novel risk factors for hypertension, and epidemiology of gout. Additional areas of active research include mineral metabolism, primary hyperparathyroidism, and acid-base. Risk factors being explored include dietary intake, 24-hour urine composition, urine and blood biomarkers, and genetic factors. Dr. Curhan spends the majority of his time on these research activities and the remainder of his time on mentoring, teaching and co-directing parts of the PASTEUR program at HMS. He is the Editor-in-Chief for the Clinical Journal of the American Society of Nephrology (CJASN). He serves on national committees including the Advisory Council for the National Center for Complementary and Alternative Medicine at NIH.

Education

Medical School

Harvard Medical School/ BWH, 1985

Residency

Massachusetts General Hospital, 1985 - 1988

Board Certifications

Internal Medicine, 1988

Fellowship

Massachusetts General Hospital, 1988 - 1991